Emtricitabine/Tenofovir Disoproxil Accordpharma

Emtricitabine/Tenofovir Disoproxil Accordpharma is a combination medication used for HIV treatment and prevention. This oral medication is manufactured by Accord Healthcare B.V. and is available in the EU market.

Emtricitabine/Tenofovir Disoproxil Accordpharma is primarily used in the management of HIV infection. It is often prescribed as part of a combination therapy to help control the virus and reduce the risk of HIV-related complications. This medication is also used for pre-exposure prophylaxis (PrEP) to prevent HIV infection in individuals at high risk.

Common effects of Emtricitabine/Tenofovir Disoproxil Accordpharma may include headache, nausea, and diarrhea. Some individuals may experience dizziness or fatigue. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Emtricitabine/Tenofovir Disoproxil Accordpharma should be handled with care. It is important to follow the prescribed dosage and administration instructions. Individuals with kidney problems should use this medication with caution. Regular monitoring of kidney function may be required during treatment.

Emtricitabine/Tenofovir Disoproxil Accordpharma may interact with other medications, including certain antibiotics, antivirals, and medications that affect kidney function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.